Advanced Enzyme Technologies allots 500 equity shares under ESOS
19 - Mar - 2025 12:00 | 48 days ago
Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,61,300 comprising of 11,18,80,650 equity shares of Rs 2 each to Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each.
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
08 - Feb - 2025 12:00 | 87 days ago
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023.
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
08 - Feb - 2025 12:00 | 87 days ago
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023.
Advanced Enzymes announces incorporation of new entity in California for laboratory testing services
05 - Dec - 2024 12:00 | 152 days ago
The Board of Directors of Advanced Enzymes USA (AEU), a wholly owned subsidiary of Advanced Enzyme Technologies has accorded its approval for formation of a new corporation in California (US) to be named as Starya Labs, Inc (Starya Labs). In view of this, Starya Labs will be a step down wholly owned subsidiary of Advanced Enzyme Technologies.
Cal-India Foods International USA (SEB), a step-down wholly owned subsidiary of Advanced Enzyme Technologies and wholly owned subsidiairy of AEU to spin-off and transfer its enzyme/probiotic laboratory testing services (SEB Lab) together with certain assets and liabilities related to the said SEB Lab into Starya Labs. The said new corporation, Starya Labs will be a wholly owned subsidiary of AEU.
Advanced Enzyme Technologies allots 500 equity shares under ESOS
19 - Mar - 2025 12:00 | 48 days ago
Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,61,300 comprising of 11,18,80,650 equity shares of Rs 2 each to Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each.
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
08 - Feb - 2025 12:00 | 87 days ago
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023.
Advanced Enzymes announces incorporation of new entity in California for laboratory testing services
05 - Dec - 2024 12:00 | 152 days ago
The Board of Directors of Advanced Enzymes USA (AEU), a wholly owned subsidiary of Advanced Enzyme Technologies has accorded its approval for formation of a new corporation in California (US) to be named as Starya Labs, Inc (Starya Labs). In view of this, Starya Labs will be a step down wholly owned subsidiary of Advanced Enzyme Technologies.
Cal-India Foods International USA (SEB), a step-down wholly owned subsidiary of Advanced Enzyme Technologies and wholly owned subsidiairy of AEU to spin-off and transfer its enzyme/probiotic laboratory testing services (SEB Lab) together with certain assets and liabilities related to the said SEB Lab into Starya Labs. The said new corporation, Starya Labs will be a wholly owned subsidiary of AEU.
Advanced Enzyme Technologies allots 500 equity shares under ESOS
19 - Mar - 2025 12:00 | 48 days ago
Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,61,300 comprising of 11,18,80,650 equity shares of Rs 2 each to Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each.
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
08 - Feb - 2025 12:00 | 87 days ago
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023.
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
08 - Feb - 2025 12:00 | 87 days ago
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023.
Advanced Enzymes announces incorporation of new entity in California for laboratory testing services
05 - Dec - 2024 12:00 | 152 days ago
The Board of Directors of Advanced Enzymes USA (AEU), a wholly owned subsidiary of Advanced Enzyme Technologies has accorded its approval for formation of a new corporation in California (US) to be named as Starya Labs, Inc (Starya Labs). In view of this, Starya Labs will be a step down wholly owned subsidiary of Advanced Enzyme Technologies.
Cal-India Foods International USA (SEB), a step-down wholly owned subsidiary of Advanced Enzyme Technologies and wholly owned subsidiairy of AEU to spin-off and transfer its enzyme/probiotic laboratory testing services (SEB Lab) together with certain assets and liabilities related to the said SEB Lab into Starya Labs. The said new corporation, Starya Labs will be a wholly owned subsidiary of AEU.
